If you think people here are criticizing NP because "you're not hearing what you want to hear," then you haven't been here very long. NP, while transparent, has little idea how to manage shareholder expectations, and that is based on his conference calls time and time again, where he first telegraphs that something meaningful is coming, and then has little/nothing to really say, and the share price tanks. Sometimes, silence is golden. He truly did make it seem as if we were going to get efficacy results last week, which is why the safety results were such a disappointment. There was no actual need to release that information at that time. We already know that leronlimab is safe.

I am in the camp that feels CytoDyn will announce something material tomorrow, either pre or post market hours, and Friday will be a great day. That being said, in dealing with NP's past calls, a pessimist is just an optimist with experience.